{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:33:46Z","timestamp":1778704426513,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08050-2","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T08:14:54Z","timestamp":1747728894000},"page":"351-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative effectiveness and safety of different progestins in combined oral contraceptives: a systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"312","author":[{"given":"Binting","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"2","key":"8050_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.NAJ.0000654304.29632.a7","volume":"120","author":"LE Britton","year":"2020","unstructured":"Britton LE, Alspaugh A, Greene MZ, McLemore MR (2020) CE: an evidence-based update on contraception. Am J Nurs 120(2):22\u201333","journal-title":"Am J Nurs"},{"issue":"1","key":"8050_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/0897190015585751","volume":"30","author":"CW Colquitt","year":"2017","unstructured":"Colquitt CW, Martin TS (2017) Contraceptive methods: a review of non barrier and barrier products. J Pharm Pract 30(1):130\u2013135","journal-title":"J Pharm Pract"},{"key":"8050_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bpobgyn.2020.03.004","volume":"66","author":"MPR Festin","year":"2020","unstructured":"Festin MPR (2020) Overview of modern contraception. Best Pract Res Clin Obstet Gynaecol 66:4\u201314","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"8050_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00404-025-07943-6","volume":"311","author":"JA Oliveira","year":"2025","unstructured":"Oliveira JA, Neves GL, Pinhati MES, de Oliveira Ribeiro Fl\u00e1via, Filho ALDS (2025) Subdermal implants vs. levonorgestrel intrauterine devices outcomes in reproductive-aged women: a systematic review and meta-analysis. Arch Gynecol Obstet 311(1):1173\u20131180","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"8050_CR5","first-page":"161","volume":"109","author":"S Schrager","year":"2024","unstructured":"Schrager S, Fox K, Lee R (2024) Abnormal uterine bleeding associated with hormonal contraception. Am Fam Physician 109(2):161\u2013166","journal-title":"Am Fam Physician"},{"issue":"24","key":"8050_CR6","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1001\/jama.2021.21392","volume":"326","author":"S Teal","year":"2021","unstructured":"Teal S, Edelman A (2021) Contraception selection, effectiveness, and adverse effects a review. JAMA 326(24):2507\u20132518","journal-title":"JAMA"},{"issue":"10","key":"8050_CR7","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s40279-020-01317-5","volume":"50","author":"KJ Elliott-Sale","year":"2020","unstructured":"Elliott-Sale KJ, McNulty KL, Ansdell P, Ansdell P, Goodall S, Hicks KM, Thomas K, Swinton PA, Dolan E (2020) The effects of oral contraceptives on exercise performance in women: a systematic review and meta-analysis. Sports Med 50(10):1785\u20131812","journal-title":"Sports Med"},{"issue":"4","key":"8050_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.contraception.2013.12.003","volume":"89","author":"FZ Stanczyk","year":"2014","unstructured":"Stanczyk FZ, Archer DF (2014) Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception 89(4):242\u2013252","journal-title":"Contraception"},{"issue":"1","key":"8050_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/17425255.2013.844229","volume":"10","author":"G Grandi","year":"2014","unstructured":"Grandi G, Cagnacci A, Volpe A (2014) Pharmacokinetic evaluation of desogestrel as a female contraceptive. Expert Opin Drug Metab Toxicol 10(1):1\u201310","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"8050_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.contraception.2021.01.001","volume":"103","author":"C Klipping","year":"2021","unstructured":"Klipping C, Duijkers I, Mawet M, Maillard C, Bastidas A, Jost M, Jean-Michel Foidart (2021) Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception 103(4):213\u2013221","journal-title":"Contraception"},{"issue":"9","key":"8050_CR11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s40265-015-0407-9","volume":"75","author":"CB Burness","year":"2015","unstructured":"Burness CB (2015) Extended-cycle levonorgestrel\/ethinylestradiol and low-dose ethinylestradiol (Seasonique(\u00ae)): a review of its use as an oral contraceptive. Drugs 75(9):1019\u20131026","journal-title":"Drugs"},{"issue":"16","key":"8050_CR12","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2165\/00003495-200565160-00007","volume":"65","author":"TM Dando","year":"2005","unstructured":"Dando TM, Curran MP (2005) Low-dose ethinylestradiol\/levonorgestrel. Drugs 65(16):2299\u20132306","journal-title":"Drugs"},{"key":"8050_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"8050_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358:j4008","journal-title":"BMJ"},{"key":"8050_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Giovane CD, Egger M, Salanti G (2020) CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med 17:1\u201319","journal-title":"PLoS Med"},{"issue":"4","key":"8050_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6504a1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK (2016) U.S. selected practice recommendations for contraceptive use. MMWR Recomm Rep 65(4):1\u201366","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"8050_CR17","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/humrep\/16.7.1527","volume":"16","author":"ESHRE Capri Workshop Group","year":"2001","unstructured":"ESHRE Capri Workshop Group (2001) Ovarian and endometrial function during hormonal contraception. Hum Reprod 16(7):1527\u20131535","journal-title":"Hum Reprod"},{"key":"8050_CR18","first-page":"43","volume":"7","author":"J Villavicencio","year":"2016","unstructured":"Villavicencio J, Allen RH (2016) Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates. Open Access J Contracept 7:43\u201352","journal-title":"Open Access J Contracept"},{"issue":"4","key":"8050_CR19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/01.AOG.0000428646.67925.9a","volume":"121","author":"ACOG committee opinion no","year":"2013","unstructured":"ACOG committee opinion no (2013) 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol 121(4):891\u2013896. https:\/\/doi.org\/10.1097\/01.AOG.0000428646.67925.9a","journal-title":"Obstet Gynecol"},{"issue":"2","key":"8050_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mcna.2022.10.014","volume":"107","author":"E Lebduska","year":"2023","unstructured":"Lebduska E, Beshear D, Spataro BM (2023) Abnormal uterine bleeding. Med Clin North Am 107(2):235\u2013246","journal-title":"Med Clin North Am"},{"key":"8050_CR21","volume-title":"Selected practice recommendations for contraceptive use","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Selected practice recommendations for contraceptive use, 3rd edn. WHO, Geneva","edition":"3"},{"issue":"7","key":"8050_CR22","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/jog.15669","volume":"49","author":"M Ono","year":"2023","unstructured":"Ono M, Hiraike O, Kitahara Y, Maekawa R, Ota I, Yoshino O, Takai Y, Iwase A (2023) Text mining in a literature review of abnormal uterine bleeding according to the FIGO classification. J Obstet Gynaecol Res 49(7):1827\u20131837","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"8050_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40834-023-00249-5","volume":"8","author":"D Shoupe","year":"2023","unstructured":"Shoupe D (2023) The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control-plus more. Contracept Reprod Med 8(1):48","journal-title":"Contracept Reprod Med"},{"key":"8050_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2022.917881","volume":"3","author":"K Fataar","year":"2022","unstructured":"Fataar K, Zweigenthal V, Harries J (2022) Providers\u2019 approaches to contraceptive provision in cape town. Front Glob Womens Health 3:917881","journal-title":"Front Glob Womens Health"},{"issue":"3","key":"8050_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/13625189809051413","volume":"3","author":"HW Halbe","year":"1998","unstructured":"Halbe HW, de Melo NR, Bahamondes L, Petracco A, Lemgruber M, de Andrade RP, da Cunha DC, Guazelli CA, Baracat EC (1998) Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene. Eur J Contracept Reprod Health Care 3(3):113\u2013120","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"8050_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0015-0282(01)02927-2","volume":"77","author":"MI Cedars","year":"2002","unstructured":"Cedars MI (2002) Triphasic oral contraceptives: review and comparison of various regimens. Fertil Steril 77(1):1\u201314","journal-title":"Fertil Steril"},{"issue":"3","key":"8050_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00404-022-06853-1","volume":"307","author":"G Grandi","year":"2022","unstructured":"Grandi G, Savio MCD, Melotti C, Facchinetti F (2022) Drospirenone 4mg in a 24+4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics. Arch Gynecol Obstet 307(3):873\u2013879","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"8050_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1262\/jrd.11-018E","volume":"57","author":"TY Fu","year":"2011","unstructured":"Fu TY, Lin CT, Tang PC (2011) Steroid hormone-regulated let-7b mediates cell proliferation and basigin expression in the mouse endometrium. J Reprod Dev 57(5):627\u2013635","journal-title":"J Reprod Dev"},{"issue":"5","key":"8050_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0039-128X(99)00109-9","volume":"65","author":"Z Tuba","year":"2000","unstructured":"Tuba Z, Bardin CW, Dancsi A, Francsics-Czinege E, Moln\u00e1r C, Cs\u00f6rgei J, Falkay G, Koide SS, Kumar N, Sundaram K, Duk\u00e1t-Abr\u00f3k V, Balogh G (2000) Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate. Steroids 65(5):266\u2013274","journal-title":"Steroids"},{"issue":"7","key":"8050_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.4065\/81.7.949","volume":"81","author":"PS David","year":"2006","unstructured":"David PS, Boatwright EA, Tozer BS, Verma DP, Blair JE, Mayer AP, Files JA (2006) Hormonal contraception update. Mayo Clin Proc 81(7):949\u2013954","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"8050_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","volume":"47","author":"R Sitruk-Ware","year":"2004","unstructured":"Sitruk-Ware R (2004) Pharmacological profile of progestins. Maturitas 47(4):277\u2013283","journal-title":"Maturitas"},{"issue":"1A","key":"8050_CR32","doi-asserted-by":"publisher","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","volume":"98","author":"PD Darney","year":"1995","unstructured":"Darney PD (1995) The androgenicity of progestins. Am J Med 98(1A):104S-110S","journal-title":"Am J Med"},{"issue":"11","key":"8050_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/00006254-199211000-00014","volume":"47","author":"RS London","year":"1992","unstructured":"London RS (1992) The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel. Obstet Gynecol Surv 47(11):777\u2013782","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"8050_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1517\/14740338.2013.788147","volume":"12","author":"C Scala","year":"2013","unstructured":"Scala C, Leone Roberti Maggiore U, Remorgida V, Venturini PL, Ferrero S (2013) Drug safety evaluation of desogestrel. Expert Opin Drug Saf 12(3):433\u2013444","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"8050_CR35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1177\/1933719116645193","volume":"23","author":"T Pakrashi","year":"2016","unstructured":"Pakrashi T, Taylor JE, Nelson A, Archer DF, Jacot T (2016) The effect of levonorgestrel on fibrinolytic factors in human endometrial endothelial cells. Reprod Sci 23(11):1536\u20131541","journal-title":"Reprod Sci"},{"issue":"6","key":"8050_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","volume":"20","author":"IJM Duijkers","year":"2015","unstructured":"Duijkers IJM, Heger-Mahn D, Drouin D, Skouby S (2015) A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen. Eur J Contracept Reprod Health Care 20(6):419\u2013427","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3 Pt 2","key":"8050_CR37","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/0002-9378(93)90331-C","volume":"168","author":"SL Corson","year":"1993","unstructured":"Corson SL (1993) Contraceptive efficacy of a monophasic oral contraceptive containing desogestrel. Am J Obstet Gynecol 168(3 Pt 2):1017\u20131020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"8050_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0010-7824(93)90078-L","volume":"48","author":"P Darney","year":"1993","unstructured":"Darney P (1993) Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials. Contraception 48(4):323\u2013337","journal-title":"Contraception"},{"issue":"10","key":"8050_CR39","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s40265-022-01738-8","volume":"82","author":"A Lee","year":"2022","unstructured":"Lee A, Syed YY (2022) Estetrol\/drospirenone: a review in oral contraception. Drugs 82(10):1117\u20131125","journal-title":"Drugs"},{"issue":"3","key":"8050_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0028-2243(94)90120-1","volume":"53","author":"A Volpe","year":"1994","unstructured":"Volpe A, Silferi M, Mauri A, Deiana P, Angioni S, Grasso A, Genazzani AR (1994) Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. Eur J Obstet Gynecol Reprod Biol 53(3):205\u2013209","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"8050_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/13625187.2017.1295437","volume":"22","author":"N Chabbert-Buffet","year":"2017","unstructured":"Chabbert-Buffet N, Jamin C, Lete I, Lobo P, Nappi RE, Pintiaux A, H\u00e4usler G, Fiala C (2017) Missed pills: frequency, reasons, consequences and solutions. Eur J Contracept Reprod Health Care 22(3):165\u2013169","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"8050_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/13625189809167251","volume":"3","author":"D Serfaty","year":"1998","unstructured":"Serfaty D, Vree ML (1998) A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 \u03bcg ethinylestradiol and either 150 \u03bcg desogestrel or 75 \u03bcg gestodene. Eur J Contracept Reprod Health Care 3(4):179\u2013189","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"8050_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0010-7824(01)00235-9","volume":"64","author":"J Endrikat","year":"2001","unstructured":"Endrikat J, Cronin M, Gerlinger C, Ruebig A, Schmidt W, D\u00fcsterberg B (2001) Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel. Contraception 64(3):201\u2013207","journal-title":"Contraception"},{"issue":"1","key":"8050_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","volume":"47","author":"P Sulak","year":"2007","unstructured":"Sulak P, Willis S, Kuehl T, Coffee A, Clark J (2007) Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47(1):27\u201337","journal-title":"Headache"},{"issue":"2","key":"8050_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.spen.2010.04.007","volume":"17","author":"A Pakalnis","year":"2010","unstructured":"Pakalnis A, Gladstein J (2010) Headaches and hormones. Semin Pediatr Neurol 17(2):100\u2013104","journal-title":"Semin Pediatr Neurol"},{"issue":"4","key":"8050_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/09513590.2011.613502","volume":"28","author":"M K\u00fc\u00e7\u00fck","year":"2012","unstructured":"K\u00fc\u00e7\u00fck M, Aksu H, Sezer SD (2012) Misconceptions about the side effects of combined oral contraceptive pills. Gynecol Endocrinol 28(4):282\u2013285","journal-title":"Gynecol Endocrinol"},{"key":"8050_CR47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1196\/annals.1290.033","volume":"997","author":"HPG Schneider","year":"2003","unstructured":"Schneider HPG (2003) Androgens and antiandrogens. Ann N Y Acad Sci 997:292\u2013306","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8050_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","volume":"491","author":"R Louw-du Toit","year":"2017","unstructured":"Louw-du Toit R, Perkins MS, Hapgood JP, Africander D (2017) Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy. Biochem Biophys Res Commun 491(1):140\u2013146","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"8050_CR49","first-page":"1816","volume":"80","author":"W Oelkers","year":"1995","unstructured":"Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R (1995) Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 80(6):1816\u20131821","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"8050_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0010-7824(96)00005-4","volume":"53","author":"D Mango","year":"1996","unstructured":"Mango D, Ricci S, Manna P, Miggiano GA, Serra GB (1996) Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. Contraception 53(3):163\u2013170","journal-title":"Contraception"},{"issue":"1","key":"8050_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4755-1-1","volume":"1","author":"R Kulier","year":"2004","unstructured":"Kulier R, Helmerhorst FM, Maitra N, G\u00fclmezoglu AM (2004) Effectiveness and acceptability of progestogens in combined oral contraceptives - a systematic review. Reprod Health 1(1):1","journal-title":"Reprod Health"},{"issue":"1","key":"8050_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/13625187.2012.728643","volume":"18","author":"Z Pastor","year":"2013","unstructured":"Pastor Z, Holla K, Chmel R (2013) The influence of combined oral contraceptives on female sexual desire: a systematic review. Eur J Contracept Reprod Health Care 18(1):27\u201343","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08050-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:08:33Z","timestamp":1757171313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08050-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["8050"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08050-2","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}